Evento
Effect of tocilizumab on HDL and LDL characteristics in patients with Rheumatoid Arthritis
Pierini, Florencia; Gandino, Ignacio; Botta, Eliana Elizabeth
; Brites, Fernando Daniel
; Meroño, Tomás
; Cerda, Osvaldo Luis; Citera, Gustavo; de Rosa, Javier Enrique; Sorroche, Patricia; Boero, Laura; Martin, Maximiliano Emanuel
; Saez, Soledad; Tetzlaff, Walter Francisco
; Soriano, Enrique
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
Tipo del evento:
Reunión
Nombre del evento:
ACR/ARP Annual Meeting
Fecha del evento:
08/11/2019
Institución Organizadora:
American College of Rheumatology;
Título de la revista:
Arthritis and Rheumatology
Editorial:
Wiley
Idioma:
Inglés
Clasificación temática:
Resumen
In patients with Rheumatoid Arthritis (RA), qualitative alterations of low and high density lipoproteins (LDL and HDL, respectively) might partially explain their increased cardiovascular risk. Tocilizumab has been associated with increase in lipids, including triglycerides (TG) and cholesterol levels, in all its lipoprotein fractions. The aim of this study was to compare, in patients with RA, the effect of tocilizumab on HDL and LDL characteristics at baseline and 3 months after the start of treatment.
Palabras clave:
HDL
,
RHEUMATOID ARTRITIS
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(OCA HOUSSAY)
Eventos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Eventos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Citación
Effect of tocilizumab on HDL and LDL characteristics in patients with Rheumatoid Arthritis; ACR/ARP Annual Meeting; Estados Unidos; 2019
Compartir